0.0%
RETA2-35Metabolic & Weight
GLP-4 Reta
GLP-4 Reta combines Retatrutide 30mg and Cagrilintide 5mg in a single prefilled Klik-pen for multi-pathway metabolic research.
Select variant
AED 1,200
Benefits
- Appetite suppression
- Energy expenditure
- Improves fat loss
- Metabolic regulation
- Body composition optimization
Important
Combination pen: Retatrutide (30mg) and Cagrilintide (5mg). Reconstitute 35mg with 2.4ml bacteriostatic water.
Click guide (Retatrutide / Cagrilintide)
- 4 clicks = 0.500mg / 0.0833mg
- 6 clicks = 0.750mg / 0.1250mg
- 8 clicks = 1.000mg / 0.1667mg
- 10 clicks = 1.250mg / 0.2083mg
Studies showed that taking it once a week is enough to see results.
Cycle
Once weekly. Follow a structured on/off protocol.
Research background
GLP-4 Reta is an advanced combination pen containing Retatrutide (30mg) and Cagrilintide (5mg) in 2.4ml solution. This combination targets four distinct metabolic receptors: GIP, GLP-1, Glucagon (via retatrutide), and Amylin (via cagrilintide). The quad-receptor approach represents the cutting edge of metabolic research, potentially offering additive effects on appetite suppression, energy expenditure, and glucose homeostasis beyond triple agonism alone.
Related compounds
AOD-5→
AOD
In stockAOD-9604 is a modified fragment of human growth hormone (hGH 176-191) researched for fat metabolism without growth-promoting effects, delivered in a prefilled Klik-pen.
AED 650
AICAR-50→
CAR
In stockAICAR is an AMPK activator researched as an exercise mimetic and metabolic regulator, delivered in a prefilled Klik-pen.
AED 500
RETA-30→
GLP-3 Reta
In stockRetatrutide is a triple GIP/GLP-1/Glucagon receptor agonist, the first of its class, delivered in a once-weekly prefilled Klik-pen.
AED 950